1. 2, 4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFRL858R/T790M. Issue 19 (1st October 2015) Authors: Chan, Shingpan; Han, Kun; Qu, Rong; Tong, Linjiang; Li, Yingjun; Zhang, Zhang; Cheng, Huimin; Lu, Xiaoyun; Patterson, Adam; Smaill, Jeff; Ren, Xiaomei; Ding, Jian; Xie, Hua; Ding, Ke Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 19(2015) Page Start: 4277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2, 4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFRL858R/T790M. Issue 19 (1st October 2015) Authors: Chan, Shingpan; Han, Kun; Qu, Rong; Tong, Linjiang; Li, Yingjun; Zhang, Zhang; Cheng, Huimin; Lu, Xiaoyun; Patterson, Adam; Smaill, Jeff; Ren, Xiaomei; Ding, Jian; Xie, Hua; Ding, Ke Journal: Bioorganic & medicinal chemistry letters Issue: Volume 25:Issue 19(2015) Page Start: 4277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. GZD824 overcomes FGFR1‐V561F/M mutant resistance in vitro and in vivo. (10th June 2021) Authors: Jiang, Kaili; Tang, Xia; Guo, Jing; He, Rui; Chan, Shingpan; Song, Xiaojuan; Tu, Zhengchao; Wang, Yuting; Ren, Xiaomei; Ding, Ke; Zhang, Zhang Journal: Cancer medicine Issue: Volume 10:Number 14(2021) Page Start: 4874 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗